Dr. Walter K. Nahm, MD, PhD

Dr. Nahm practices at Cabrillo Surgery Center in San Diego, California.

Dr. Nahm's NPI, 1467447284, was assigned on September 19, 2005. Dr. Nahm graduated from Baylor College Of Medicine in 1998. Dr. Nahm's California license number on file is A78569.

Dr. Nahm's primary practice is Cabrillo Surgery Center, at 7695 Cardinal Court, Suite 220, San Diego, CA 92123. The practice phone is (858) 278-8835.

Dr. Nahm's primary practice is Cabrillo Surgery Center in San Diego, California. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Nahm to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nahm practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Nahm's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Nahm is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Nahm's licenses on file in 2 states: California and Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, facial skin infection and itchy rashes among the conditions Dr. Nahm treats.

CMS data shows 25,903 Medicare services from Dr. Nahm across 45 procedure codes in 2024, for 396 Medicare patients. Medicare paid $4,793,625 for them.

CMS counts 396 Medicare patients who saw Dr. Nahm in 2024. The largest group is 65 to 74, with 173 patients. 72% of them have high blood pressure, and 72% have high cholesterol. 42% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Nahm's median patient age at 64, with 55% women.

In 2024, Dr. Nahm wrote 2,660 Medicare Part D claims for 452 patients. 95% of them were for generic drugs. CMS names the drug for 2,560 of them, across 35 drugs with 11 or more claims each, at $645,655 in total drug cost. In 2023, CMS named 2,734 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Nahm for performance year 2024, reported individually. Dr. Nahm accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 368 procedures of melanoma (skin cancer) excision by Dr. Nahm, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 57 papers to Dr. Nahm, published from 2013 to 2024. 2014 was the busiest year, with 2. The most frequent topics are Signal Processing, Computer-Assisted, Equipment Design and Ethanol. Dr. Nahm has published most often in Biomed Tech (Berl). Dr. Nahm's most frequent co-authors are Evangelos V. Badiavas, MD, Jeffrey Lloyd Noebels, MD and Leon H. Kircik, MD.

Dmand AI links Dr. Nahm to 16 clinical trials, 4 of them phase 2 studies. Conditions studied include Eczema, Dermatitis, Atopic and Acneiform Eruptions. Eli Lilly and Company sponsors the most, 9. Open Payments lists research payments to Dr. Nahm that name 5 trials.

CMS Open Payments shows 76 general payments to Dr. Nahm from 17 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 45% of the total. UCB, Inc. paid the most, $1,875. It also lists 8 research payments totaling $15,885 from 2017 to 2022, naming 5 clinical trials.

Dmand AI lists 4 awards for Dr. Nahm, most recently Whos Who in 2011.

Dr. Nahm graduated from Baylor College Of Medicine in 1998. Dr. Nahm is a member of AAD and ASDS.

Dr. Nahm is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.